金沙官网8331澳门


Latest results announcements and presentations金沙国际


金沙官网8331澳门


Capital markets event - Meet AZN management: ASCO 2020金沙官网8331澳门

1 June 2020

Opening session

MP3

Tagrisso and immuno-oncology

MP3

Enhertu and breast cancer

MP3

Lynparza

MP3

Calquence and haematology

MP3


First-quarter 2020 results金沙官网8331澳门

29 April 2020


Full-year and Q4 2019 results金沙官网8331澳门

14 February 2020


Epidemiology data update金沙官网8331澳门

14 February 2020

金沙官网8331澳门


General investor presentation金沙官网8331澳门

24 December 2019


Investor science conference call: American Society of Hematology 2019金沙官网8331澳门

10 December 2019

Investor conference science conference call – ASH 2019 audio replay

MP3


Investor science conference call: American College of Rheumatology 2019金沙官网8331澳门

13 November 2019

Investor science conference call - ACR 2019 audio replay

MP3


Investor science conference call: American Society of Nephrology Kidney Week 2019金沙官网8331澳门

11 November 2019

Investor science conference call - ASN 2019 audio replay

MP3


Year-to-date and Q3 2019 Results金沙官网8331澳门

24 October 2019


Investor science conference call: European Society for Medical Oncology (ESMO) Congress 2019金沙官网8331澳门

30 September 2019


Investor science conference call: Farxiga's DAPA-HF trial at ESC 2019金沙官网8331澳门

1 September 2019


H1 2019 Results金沙官网8331澳门

25 July 2019


‘Meet AZN management’ at 2019 ASCO Annual Meeting金沙官网8331澳门

3 June 2019


Q1 2019 Results金沙官网8331澳门

26 April 2019


Collaboration on trastuzumab deruxtecan Investor conference call金沙官网8331澳门

29 March 2019


Full-Year 2018 Results金沙官网8331澳门

14 February 2019

金沙官网8331澳门


Year-end webcast for investors and analysts on China and Emerging Markets金沙官网8331澳门

13 December 2018

Year-End Investor & Analyst Webcast, China and Emerging Markets video

Video


AHA Scientific Sessions 2018金沙官网8331澳门

12 November 2018


Year-To-Date and Q3 2018 Results金沙官网8331澳门

8 November 2018


H1 2018 Results金沙官网8331澳门

26 July 2018


AstraZeneca Investor Event at the 2018 ASCO Annual Meeting金沙官网8331澳门

1 June 2018


Q1 2018 Results金沙官网8331澳门

18 May 2018


Full-Year 2017 Results金沙官网8331澳门

2 February 2018


金沙官网8331澳门


Investor science event: Late-stage pipeline webcast金沙官网8331澳门

14 December 2017


Year-To-Date and Q3 2017 Results金沙官网8331澳门

9 November 2017


AstraZeneca Investor Science Event at ERS 2017金沙官网8331澳门

13 September 2017


AstraZeneca Investor Science Event at ESMO 2017金沙官网8331澳门

8 September 2017


H1 2017 Results金沙官网8331澳门

27 July 2017


General Investor presentation金沙官网8331澳门

16 June 2017


AstraZeneca Investor Science Event at 2017 ASCO Annual Meeting金沙官网8331澳门

5 June 2017


Q1 2017 Results金沙官网8331澳门

27 April 2017


Full-Year and Q4 2016 Results金沙官网8331澳门

2 February 2017


金沙官网8331澳门


Second year-end late-stage pipeline investor science webcast金沙官网8331澳门

15 December 2016


Year-to-date and Q3 2016 Results金沙官网8331澳门

10 November 2016


Investor Relations Benelux roadshow金沙官网8331澳门

8 September 2016


ERS Investor science webcast金沙官网8331澳门

7 September 2016


DNA Damage Response analyst science event金沙官网8331澳门

5 September 2016


H1 2016 Results金沙官网8331澳门

28 July 2016


AstraZeneca Investor Science Event at ASCO 2016金沙官网8331澳门

7 June 2016


Q1 2016 Results金沙官网8331澳门

29 April 2016


Full-Year and Q4 2015 Results金沙官网8331澳门

4 February 2016


J.P. Morgan Healthcare Conference 2016金沙官网8331澳门

13 January 2016


金沙官网8331澳门


Majority stake investment in Acerta Pharma金沙官网8331澳门

17 December 2015


Late-stage pipeline call金沙官网8331澳门

2 December 2015


American College of Rheumatology (ACR) 2015 Investor science conference call金沙官网8331澳门

11 November 2015


Acquisition of ZS Pharma金沙官网8331澳门

6 November 2015


Year-to-date and Q3 2015 results金沙官网8331澳门

5 November 2015


H1 2015 results金沙官网8331澳门

30 July 2015


American Society of Clinical Oncology (ASCO) 2015 Investor science event金沙官网8331澳门

1 June 2015


AstraZeneca Mölndal 金沙官网8331澳门

25 May 2015


First quarter results 2015 金沙官网8331澳门

24 April 2015


American College of Cardiology (ACC) 2015 Investor science conference call金沙官网8331澳门

16 March 2015


Fourth quarter and full year results 2014金沙官网8331澳门

5 February 2015


33rd J.P. Morgan Healthcare Conference金沙官网8331澳门

14 January 2015


金沙官网8331澳门


AstraZeneca Investor Day金沙官网8331澳门

18 November 2014


Third quarter and nine months results 2014 金沙官网8331澳门

6 November 2014


European Society for Medical Oncology (ESMO) 2014 金沙官网8331澳门

28 September 2014


Second quarter and half year results 2014 金沙官网8331澳门

31 July 2014


Strategic Transaction with Almirall in Respiratory Disease金沙官网8331澳门

30 July 2014


American Society of Clinical Oncology (ASCO) 2014金沙官网8331澳门

3 June 2014


American Thoracic Society (ATS) 2014 AstraZeneca Analyst briefing金沙官网8331澳门

20 May 2014


AstraZeneca strategy update 金沙官网8331澳门

6 May 2014


First quarter results 2014 金沙官网8331澳门

24 April 2014


Fourth quarter and full year Results 2013 金沙官网8331澳门

6 February 2014


J.P. Morgan Healthcare conference presentation金沙官网8331澳门

14 January 2014


金沙官网8331澳门


Global diabetes alliance analyst call 金沙官网8331澳门

19 December 2013


MedImmune R&D Roadshow 金沙官网8331澳门

7 November 2013


Third quarter and nine months results 2013 金沙官网8331澳门

31 October 2013


Second quarter and half year results 2013 金沙官网8331澳门

1 August 2013


American Society of Clinical Oncology (ASCO) 2013 briefing 金沙官网8331澳门

1 June 2013


First quarter results 2013金沙官网8331澳门

25 April 2013


AstraZeneca Investor Day金沙官网8331澳门

21 March 2013


Fourth quarter and full year results 2012金沙官网8331澳门

31 January 2013


Partnering for Growth: J.P. Morgan Healthcare Conference金沙官网8331澳门

9 January 2013


金沙官网8331澳门


Fostamatinib analyst briefing金沙官网8331澳门

15 November 2012

Fostamatinib analyst briefing video

Play Video


Third quarter and nine months results 2012金沙官网8331澳门

25 October 2012


Naloxegol educational presentation金沙官网8331澳门

18 October 2012

Naloxegol educational presentation video

Play Video


Second quarter and half year results 2012金沙官网8331澳门

26 July 2012


AstraZeneca business update金沙官网8331澳门

2 July 2012


R&D Roundtable金沙官网8331澳门

14 June 2012


First quarter results 2012金沙官网8331澳门

26 April 2012


Fourth quarter and full year results 2011金沙官网8331澳门

2 February 2012


30th Annual J.P. Morgan Healthcare Conference金沙官网8331澳门

11 January 2012


Upcoming events金沙国际

J.P. Morgan European Healthcare Conference [Management] 金沙官网8331澳门

H1 2020 Results金沙官网8331澳门


SEC filings金沙国际

SEC filings are those documents that we are required to file by virtue of our listing on the New York Stock Exchange. They contain mainly financial information.

These documents are also available for viewing on the SEC website at www.sec.gov. The Company will send any holder of the Company’s securities, upon request, a hard copy of the Company’s complete audited financial statements free of charge. Requests may be made by writing to:

Company Secretary
AstraZeneca PLC
1 Francis Crick Avenue
Cambridge Biomedical Campus
Cambridge CB2 0AA



金沙国际

 


金沙国际

金沙官网8331澳门

金沙网站

Thomas Kudsk Larsen

金沙官网8331澳门

Henry Wheeler

Oncology

金沙网站

Josie Afolabi

BioPharmaceuticals (Respiratory & Immunology)

金沙官网手机版

Craig Marks

Finance, fixed income

金沙集团

Christer Gruvris

BioPharmaceuticals (CV, Metabolism)

金沙app官方下载

Tom Waldron

Other medicines

金沙官网9304

Jennifer Kretzmann

Corporate access, retail investors

金沙app软件

Nick Stone

BioPharmaceuticals (Renal), ESG

US general enquiries